|1.||Affourtit, Charles: 4 articles (01/2015 - 01/2008)|
|2.||Brand, Martin D: 4 articles (01/2013 - 01/2008)|
|3.||Baffy, György: 4 articles (04/2008 - 04/2002)|
|4.||Huang, Yu: 3 articles (10/2014 - 04/2012)|
|5.||Li, P Andy: 3 articles (01/2012 - 06/2009)|
|6.||Wands, Jack R: 3 articles (04/2008 - 09/2004)|
|7.||Dando, Ilaria: 2 articles (03/2015 - 10/2012)|
|8.||Palmieri, Marta: 2 articles (03/2015 - 10/2012)|
|9.||Dalla Pozza, Elisa: 2 articles (03/2015 - 10/2012)|
|10.||Donadelli, Massimo: 2 articles (03/2015 - 10/2012)|
01/01/2013 - "Measuring mitochondrial uncoupling protein-2 level and activity in insulinoma cells."
01/01/2001 - "Effects of adenoviral overexpression of uncoupling protein-2 and -3 on mitochondrial respiration in insulinoma cells."
07/01/2014 - "Uncoupling protein-2 mediates the protective action of berberine against oxidative stress in rat insulinoma INS-1E cells and in diabetic mouse islets."
01/01/2015 - "Uncoupling protein-2 attenuates palmitoleate protection against the cytotoxic production of mitochondrial reactive oxygen species in INS-1E insulinoma cells."
03/01/2011 - "Uncoupling protein-2 attenuates glucose-stimulated insulin secretion in INS-1E insulinoma cells by lowering mitochondrial reactive oxygen species."
|2.||Body Weight (Weight, Body)
10/01/2012 - "Jueming Prescription reduces body weight by increasing the mRNA expressions of beta3-adrenergic receptor and uncoupling protein-2 in adipose tissue of diet-induced obese rats."
01/01/2011 - "No significant differences in adipocyte size and hepatic gene expression were observed after treatment with NT-BVT compared with vehicle treated mice, though NT-BVT also decreased body weight gain, improved glucose tolerance, and increased uncoupling protein-2 (UCP-2) mRNA levels in muscle. "
01/01/2011 - "they delay the manifestations of hypertension, diabetes, nephropathy, cardiovascular disease, and cancer; increase body temperature; reduce body weight, plasma glucose, insulin, and insulin-like growth factor-1; ameliorate insulin sensitivity; lower protein, lipid, and DNA oxidation, and mitochondrial H(2)O(2) production; and increase uncoupling protein-2 and sirtuin expression. "
09/15/2012 - "We further found that deficiency of mitochondrial uncoupling protein 2 (UCP2), which reduces reactive oxygen species (ROS) production and functions as upstream to the K-ATP channel in determining vulnerability of DA neurons, abolished the protective effects of H(2)S against either DA neuron degeneration in the PD mouse model or MPP(+)-induced injury in primary mesencephalic neurons. "
|4.||Aortic Valve Insufficiency (Aortic Regurgitation)
12/01/2015 - "This paper deals with the role of uncoupling protein-2 (UCP2) in cancer. "
12/01/2015 - "Overexpression of uncoupling protein-2 in cancer: metabolic and heat changes, inhibition and effects on drug resistance."
01/01/2013 - "Mitochondrial uncoupling protein 2 is up-regulated in human head and neck, skin, pancreatic, and prostate tumors."
04/01/2010 - "Uncoupling protein-2 and cancer."
04/15/2008 - "The mitochondrial uncoupling protein-2 promotes chemoresistance in cancer cells."
|1.||Reactive Oxygen Species (Oxygen Radicals)
|2.||Messenger RNA (mRNA)
|4.||Adenosine Triphosphate (ATP)
|7.||Insulin Receptor Substrate Proteins
|10.||Mitochondrial DNA (mtDNA)
|3.||Bone Marrow Transplantation (Transplantation, Bone Marrow)